We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+8.56%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$678M
AUM Growth
-$321M
Cap. Flow
-$353M
Cap. Flow %
-52.06%
Top 10 Hldgs %
8.43%
Holding
1,464
New
537
Increased
157
Reduced
250
Closed
520

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.58M
2
CRWD icon
CrowdStrike
CRWD
+$3.75M
3
LHX icon
L3Harris
LHX
+$3.23M
4
JNJ icon
Johnson & Johnson
JNJ
+$3.1M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.96M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$12.7M
2
VZ icon
Verizon
VZ
+$9.98M
3
CMCSA icon
Comcast
CMCSA
+$7.56M
4
F icon
Ford
F
+$6.17M
5
AEP icon
American Electric Power
AEP
+$5.84M

Sector Composition

Rank Sector Weight
1 Technology 20.33%
2 Financials 14.02%
3 Healthcare 13.64%
4 Industrials 11.99%
5 Consumer Discretionary 11.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALBO
1451
DELISTED
Albireo Pharma Inc
ALBO
– –
-10,010
Closed -$194K
MNRL
1452
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
– –
-17,277
Closed -$426K
SCPS
1453
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
– –
-10,940
Closed -$2.65K
LOTZ
1454
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
– –
-83,048
Closed -$24.9K
IS
1455
DELISTED
ironSource Ltd.
IS
– –
-18,923
Closed -$65.1K
TWTR
1456
DELISTED
Twitter, Inc.
TWTR
– –
-130,484
Closed -$5.72M
CCXI
1457
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-5,671
Closed -$293K
ZY
1458
DELISTED
Zymergen Inc. Common Stock
ZY
– –
-94,949
Closed -$264K
IEA
1459
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
– –
-22,834
Closed -$309K
GBT
1460
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-8,308
Closed -$566K
ARCH
1461
DELISTED
Arch Resources, Inc.
ARCH
– –
-4,675
Closed -$554K
ATVI
1462
DELISTED
Activision Blizzard
ATVI
– –
-21,874
Closed -$1.63M
IBTX
1463
DELISTED
Independent Bank Group, Inc.
IBTX
– –
-5,258
Closed -$323K
ENV
1464
DELISTED
ENVESTNET, INC.
ENV
– –
-17,465
Closed -$775K
55 56 57 58
59

Similar funds

HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
LFG
Lazard Frères Gestion Paris, France $5.07B AUM 20.66% 1-Year Est. Return
JIM
Jensen Investment Management Lake Oswego, Oregon $5.07B AUM 4.98% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.02B AUM 21.87% 1-Year Est. Return

Y-Intercept (HK)'s Q4 2022 Portfolio in Review

As of Q4 2022, Y-Intercept (HK) held 1,464 positions worth $678M, down 32% from $1,000M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Y-Intercept (HK) withdrew a net $353M in Q4 2022, closing 520 positions and reducing 250 holdings. Its most notable exit was Verizon, an estimated $9.98M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Y-Intercept (HK) opened a new position in Bristol-Myers Squibb worth $4.37M.

  • Y-Intercept (HK)'s largest Q4 2022 buy was Bristol-Myers Squibb: 60,782 shares worth $4.37M.
  • Y-Intercept (HK) added most to Walmart Inc in Q4 2022, an estimated $2.76M increase.
  • Y-Intercept (HK)'s biggest Q4 2022 reduction was Chevron, cutting an estimated $12.7M.
  • Y-Intercept (HK) fully exited Verizon in Q4 2022, selling an estimated $9.98M.
  • Y-Intercept (HK)'s ten largest holdings make up 8.4% of its $678M portfolio in Q4 2022.
  • Y-Intercept (HK) opened 537 new positions and closed 520 in Q4 2022.
  • Y-Intercept (HK)'s portfolio value fell 32% quarter-over-quarter to $678M.

Based on Y-Intercept (HK)'s 13F filing for Q4 2022, filed 14 Feb 2023.